J&J’s Remicade faces further biosimilar competition in US
FDA approves Samsung Bioepis biosimilar.
X
J&J’s Remicade faces further biosimilar competition in US
https://pharmaphorum.com/news/jjs-remicade-faces-biosimilar-competition-us/
Samsung Bioepis
UK court overturns AbbVie Humira patents
Decision paves way for cheaper competitor in autumn 2018.
Challenge to UK Humira patent begins
Samsung to take on patent thicket surrounding Humira.
Samsung Bioepis files Herceptin biosimilar in EU
South Korean firm trying to copy breast cancer blockbuster.
1 2